homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

January 11, 2006

VLST Corp.

Seattle-based VLST Corp., a biotech company focused on treating autoimmune and inflammatory disorders, and Accelerator Corp., an investment company that supports biotech companies, said Martin A. Simonetti has been named president and chief executive officer of VLST, and Steven Gillis, Ph.D., will join as executive chairman of VLST's board of directors. Simonetti worked for Dendreon, Amgen and Genentech.




Email or user name:
Password:
 
Forgot password? Click here.